IP Library Granted Patent US 9,669,173
Granted Patent B2
US 9,669,173 · App. 14/104,842 · Granted Jun 6, 2017

Continuous positive airway pressure therapy auto-titration

Inventors: Leonardo Alberto Baloa Welzien (Lake Forest, CA); Masoud Vahidi (Laguna Hills, CA); Samir S. Ahmad (San Diego, CA)
Assignee: Breathe Technologies, Inc.
A61M16/0069A61B5/14551A61B5/4818A61B5/4836A61M16/0051A61M16/06A61M16/208A61M2016/0027A61M2205/3344A61M2230/205A61M2230/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,669,173
App. No.
14/104,842
Granted
Jun 6, 2017
Kind
B2
Abstract

Adapting a patient to an airway pressure support therapy is disclosed. An initial prescription pressure level is derived from a respiratory disturbance index diagnosis. A pressure ramping slope is generated from the initial prescription pressure level and a received initial pressure level. Increasing levels of pressure are delivered to the patient as defined by the pressure ramping slope. The pressure ramping slope is adjusted based upon derived usage duration trends, and the prescription pressure level is adjusted based upon measured apnea/hypopnea index variations resulting from the delivered increasing levels of pressure to the patient.

Claims (49)

1. A method for adapting a patient to an airway pressure support therapy, the method comprising:

deriving an initial prescription pressure level from a respiratory disturbance index diagnosis;

generating a pressure ramping slope from the initial prescription pressure level and a received initial pressure level;

delivering increasing levels of pressure to the patient as defined by the pressure ramping slope;

adjusting the pressure ramping slope based upon derived usage duration trends; and

adjusting the prescription pressure level based upon measured apnea/hypopnea index variations resulting from the delivered increasing levels of pressure to the patient;

wherein the usage duration trends are derived from a median use duration and a weighted average of use durations over one or more sessions for a predetermined duration window.

2. The method of claim 1 , wherein the apnea/hypopnea index variations is based upon a measurement of the apnea/hypopnea index during one session, a subsequent measurement of the apnea/hypopnea index during another session.

3. The method of claim 2 , wherein the secondary pressure ramping strategy includes an adjustment to the default ramp duration.

4. The method of claim 3 , wherein the default ramp duration is increased in response to a decreasing usage trend.

5. The method of claim 3 , wherein the default ramp duration is decreased in response to an increasing usage trend.

6. The method of claim 2 , wherein the initial respiratory disturbance index is incremented at every occurrence of the oxygen saturation measurement dropping below a predetermined threshold value during the diagnostic mode.

7. The method of claim 2 , wherein the starting pressure level is manually entered into a user interface of the CPAP therapy device.

8. The method of claim 2 , wherein the initial respiratory disturbance index is incremented at every occurrence of a patient flow estimate derived from the patient interface pressure measurements and the machine pressure measurements dropping below a predetermined threshold value during the diagnostic mode.

9. The method of claim 8 , wherein the diagnosed treatment pressure level is generated from a function of the initial respiratory disturbance index and a mean of the patient oxygen saturation measurements made during the diagnostic mode.

10. The method of claim 8 , further comprising:

measuring an apnea/hypopnea index during one session in the titration mode; and

adjusting the diagnosed treatment pressure level for another subsequent session based upon the measured apnea/hypopnea index in the one session.

11. The method of claim 10 , further comprising:

measuring the apnea/hypopnea index during the subsequent session;

deriving an apnea/hypopnea index degree of variance from a difference between the measured apnea/hypopnea index in the one session and the measured apnea/hypopnea index in the subsequent session and the adjustment to the diagnosed treatment pressure level; and

adjusting the diagnosed treatment pressure level based upon the derived apnea/hypopnea index degree of variance.

12. The method of claim 11 , wherein the diagnosed treatment pressure level is decreased when there is a positive apnea/hypopnea index degree of difference.

13. The method of claim 11 , wherein the diagnosed treatment pressure is increased when there is a negative apnea/hypopnea index degree of difference over a first predetermined limit and the measured apnea/hypopnea index in the one session is greater than a second predetermined limit.

14. The method of claim 11 , wherein the diagnosed treatment pressure is unmodified when there is a negative apnea/hypopnea index degree of difference less than a first predetermined limit and the measured apnea/hypopnea index in the one session is greater than a second predetermined limit.

15. The method of claim 11 , wherein the diagnosed treatment pressure is unmodified when there is a negative apnea/hypopnea index degree of difference less than a first predetermined limit and the measured apnea/hypopnea index in the one session is less than a second predetermined limit.

16. A method for titrating a patient to prescription airway pressure with a continuous positive airway pressure (CPAP) therapy device, the method comprising:

generating an initial respiratory disturbance index based upon patient oxygen saturation measurements, patient interface pressure measurements, and machine pressure measurements during a diagnostic mode;

setting a diagnosed treatment pressure level and a starting pressure level;

generating an initial pressure ramping strategy from the diagnosed treatment pressure level, the starting pressure level, and a default ramp duration;

applying the initial pressure ramping strategy to the patient during a titration mode;

deriving a usage trend from a median use duration and a weighted average of use durations over one or more sessions for a predetermined duration window;

generating a secondary pressure ramping strategy from the initial treatment pressure level, and the default ramp duration adjusted in response to the usage trend; and

applying the secondary pressure ramping strategy to the patient during a subsequent session in the titration mode.

17. An article of manufacture comprising a non-transitory program storage medium readable by a data processor of a CPAP therapy device, the medium tangibly embodying one or more programs of instructions executable by the data processor to perform a method for titrating a patient to prescription airway pressure with the CPAP therapy device, the method comprising:

generating an initial respiratory disturbance index based upon patient oxygen saturation measurements, patient interface pressure measurements, and machine pressure measurements during a diagnostic mode;

setting a diagnosed treatment pressure level and a starting pressure level;

generating an initial pressure ramping strategy from the diagnosed treatment pressure level, the starting pressure level, and a default ramp duration;

applying the initial pressure ramping strategy to the patient during a titration mode;

deriving a usage trend from a use duration for a single session and a weighted average of use duration over one or more sessions for a predetermined duration window;

generating a secondary pressure ramping strategy from the initial treatment pressure level, and the default ramp duration adjusted in response to the usage trend; and

applying the secondary pressure ramping strategy to the patient during a subsequent session in the titration mode.

18. The article of manufacture of claim 17 , wherein the secondary pressure ramping strategy includes an adjustment to the default ramp duration.

19. The article of manufacture of claim 17 , wherein the method further includes the steps of:

measuring an apnea/hypopnea index during one session in the titration mode; and

adjusting the diagnosed treatment pressure level for another subsequent session based upon the measured apnea/hypopnea index in the one session;

measuring the apnea/hypopnea index during the subsequent session;

deriving an apnea/hypopnea index degree of variance from a difference between the measured apnea/hypopnea index in the one session and the measured apnea/hypopnea index in the subsequent session and the adjustment to the diagnosed treatment pressure level; and

adjusting the diagnosed treatment pressure level based upon the derived apnea/hypopnea index degree of variance.

Assignments (11)
RELEASE OF SECURITY INTEREST (DATED OCTOBER 11, 2019) Recorded Dec 14, 2021
From: JPMORGAN CHASE BANK, N.A.
To: BREATHE TECHNOLOGIES, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM, INC.; VOALTE, INC.; BARDY DIAGNOSTICS, INC.; HILL-ROM HOLDINGS, INC.
Reel/Frame 058516/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 9, 2019
From: SOLAR CAPITAL LTD.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 050314/0707 →
TERMINATION OF PATENT SECURITY AGREEMENT Recorded Mar 1, 2018
From: SOLAR CAPITAL LTD.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 045484/0302 →
SECURITY INTEREST Recorded Jan 8, 2018
From: BREATHE TECHNOLOGIES, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 045020/0420 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Mar 27, 2017
From: BREATHE TECHNOLOGIES, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 042097/0776 →
MERGER Recorded Mar 24, 2017
From: BREATHE TECHNOLOGIES, INC.
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 041735/0581 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Dec 29, 2016
From: BREATHE TECHNOLOGIES, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 041222/0174 →
RELEASE OF SECURITY INTEREST Recorded Nov 9, 2015
From: TRIPLEPOINT CAPITAL LLC
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 037071/0207 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 033453 FRAME: 0074. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Sep 17, 2014
From: BREATHE TECHNOLOGIES, INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 033763/0523 →
SECURITY INTEREST Recorded Jul 31, 2014
From: BREATHE TECHNOLOGIES, INC.
To: TRIPLEPOINTCAPITAL LLC
Reel/Frame 033453/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2013
From: AHMAD, SAMIR; VAHIDI, MASOUD; BALOA, LEONARDO
To: BREATHE TECHNOLOGIES, INC.
Reel/Frame 031775/0912 →
Continuity (1)
Related Publication 20150165143A1 · Jun 18, 2015